Home  >  Products  >  LPA (lipoprotein, Lp(a)) Blocking Peptide (the N terminal of LPA)(100ug)
LPA (lipoprotein, Lp(a)) Blocking Peptide (the N terminal of LPA)(100ug)

LPA (lipoprotein, Lp(a)) Blocking Peptide (the N terminal of LPA)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LPA Antibody (ARP60282_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60282
Size: 100ug
Weight: 120kDa
Gene: 4018
Format: Lyophilized powder
Target: LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the protein contains 2-43 copies of kringle-type domains.
Alternative names: LP; AK38; APOA; LPA
See Full Product Listings >